Likun Li
Assistant Professor
Department of Genitourinary Medical Oncology
MD Anderson Cancer Center
United States of America
Biography
Degree-Granting Education 1989 Xiamen University, Fujian Province, CHN, PhD, Cell Biology 1985 Xiamen University, Fujian Province, CHN, MS, Cell Biology 1982 Xiamen University, Fujian Province, CHN, BS, Biology Postgraduate Training 1993-1997 Research Fellowship, Department of Biochemistry and Cell Biology, Rice University, Houston, TX 1989-1992 Research Fellowship, Department of Botany, The University of Texas at Austin, Austin, TX
Research Interest
Genitourinary Medical Oncology
Publications
-
Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Takahiro H, Dobashi M, Zhang W, Efstathiou E, Maity SN, Aparicio AM, Li Ning Tapia EM, Troncoso P, Broom B, Xiao L, Lee HS, Lee JS, Corn PG, Navone N, Thompson TC. Targeting Poly(ADP-Ribose) Polymerase and the c-Myb-Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer. Sci Signal 7 (326) :ra47, 2014
-
Karanika S, Karantanos T, Kurosaka S, Wang J, Hirayama T, Yang G, Park S, Golstov AA, Tanimoto R, Li L, Thompson TC. GLIPR1-?TM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells. Mol Cancer 14:122, 2015.
-
Basourakos SP, Li L, Aparicio AM, Corn PG, Kim J, Thompson TC. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions. Curr Med Chem 24 (15) :1586-1606,
